Clinical Trial Update: Fosamprenavir Versus Other Protease Inhibitors [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing Fosamprenavir to other protease inhibitors in HIV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Fosamprenavir (fosamprenavir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus I | Phase 3 | Status: COMPLETED